Oncogenomics lab

The focus of our research is to identify targetable genetic alterations in epithelial cancers to find oncogenic drivers and molecular markers that associate with drug sensitivity and resistance using different in vitro and ex vivo tumor models. Our group is part of the Genome-Scale Biology Research Program at the Research Programs Unit, University of Helsinki. Monnilab operates in close connection with Biomedicum Functional Genomics Unit (FuGU), which provides services in genome analyses and is part of the HiLIFE Institute.